Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000597.SZ

HOLDREMOVE

Northeast Pharmaceutical Group Co., Ltd. · Healthcare · China · $983M · Avg Vol: $8M/d

64
StockRank
Q
52
V
62
M
38
P/E (TTM)
27.1x
ROE
3.5%
D/E
0.3x
Dividend %
1.2%
AI CONVICTION THESIS

Northeast Pharmaceutical is a generic pharmaceutical and API manufacturer. It is highly vulnerable to rising input costs and severe domestic price compression in China, making it a casualty of the shift toward high-moat CDMOs.

COMPANY DESCRIPTION

Northeast Pharmaceutical Group is a major pharmaceutical manufacturer producing active pharmaceutical ingredients (APIs), generic formulations, and nutritional supplements. The company is one of the world's largest producers of Vitamin C and holds a strong domestic position in anti-infective and central nervous system drugs. It operates as a vertically integrated, large-scale industrial player with a significant global export footprint.

FINANCIAL SUMMARY

Year20212022202320242025CAGR
Revenue1.3B1.2B1.1B1.0B-7.0%
EPS0.040.040.040.03-10.4%
Shares1.4B1.4B1.4B1.4B-0.5%
Debt30M330M328M241M317M81.0%
Equity674M737M786M817M6.6%
Op CF164M87M112M164M-0.1%
Inv CF-38M-34M-42M-13M
Fin CF-9M56M-170M-35M
Loading...
PRICE (1M)-9.6%
0.640.670.700.720.75May 6May 27Jun 16
SMA 50SMA 200
Close
$0.66
RSI (14)
41.2
52W High
$0.99
From 52W High
0.7%

SCORE BREAKDOWN

Quality
52
ROIC
5.6%58.7
ROE
3.5%52.5
GP/Assets
18.2%42.5
Op. Margin
4.9%54.1
FCF/Assets
7.2%79.1
Piotroski
83.5
Int. Cover
7.2x59.8
D/E Ratio
0.32x41.4
Current Ratio
1.15x14.2
Value
62
P/E (TTM)
27.1x41.4
EV/EBITDA
6.3x54.5
P/FCF
49.0x88.3
P/B
1.2x74.4
P/S
0.9x85.4
Div Yield
1.2%33.2
Momentum
38
52W High %
67%51.4
RS 6M
-30%41.9
SMA 50/200
0.92x41.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
-27%20.1

FUNDAMENTALS

Market Cap
$983M
P/E (Forward)
Gross Margin
32.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000597.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
000597.SZNortheast Pharmaceutical Group Co., Ltd.(you)$983M64HOLD
600195.SSChina Animal Husbandry Industry Co., Ltd.$996M64HOLD
600557.SSJiangsu Kanion Pharmaceutical Co.,Ltd.$1.1B65HOLD
2186.HKLuye Pharma Group Ltd.$1.1B61HOLD
002550.SZChangzhou Qianhong Biopharma CO.,LTD$1.2B66BUY
603439.SSGuizhou Sanli Pharmaceutical Co.,Ltd$984M70BUY
688566.SSJiangsu Jibeier Pharmaceutical Co., Ltd.$741M65BUY
300039.SZShanghai Kaibao Pharmaceutical CO.,Ltd$822M68BUY
300725.SZPharmaBlock Sciences (Nanjing), Inc.$1.2B60HOLD
601089.SSBeijing Foyou Pharma CO.,LTD$1.3B61HOLD

Peer medians: ROE 4.8% · P/E 27.9x · Gross margin 53.1%

Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) — Stock Score Summary

Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) has a MoatMap StockRank of 64/100 based on Quality (52/100), Value (62/100), and Momentum (38/100) factor scores. The current signal is HOLD. Northeast Pharmaceutical is a generic pharmaceutical and API manufacturer. It is highly vulnerable to rising input costs and severe domestic price compression in China, making it a casualty of the shift toward high-moat CDMOs.

Northeast Pharmaceutical Group is a major pharmaceutical manufacturer producing active pharmaceutical ingredients (APIs), generic formulations, and nutritional supplements. The company is one of the world's largest producers of Vitamin C and holds a strong domestic position in anti-infective and central nervous system drugs. It operates as a vertically integrated, large-scale industrial player with a significant global export footprint.

Key Financial Metrics

Price$0.66
Market Cap$983M
P/E (TTM)27.06
Price/Book1.18
Return on Equity3.5%
Return on Invested Capital5.6%
Debt/Equity32.44
Gross Margin32.7%
Operating Margin4.9%
Revenue Growth3.0%
Dividend Yield1.2%
Free Cash Flow$20M

Northeast Pharmaceutical Group Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Northeast Pharmaceutical Group Co., Ltd.’s (000597.SZ) StockRank?
MoatMap’s StockRank for Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) is 64/100, with a Hold signal. It is a composite of Quality (52), Value (62), and Momentum (38) factor ranks across MoatMap’s 19,000+ stock universe.
Does Northeast Pharmaceutical Group Co., Ltd. have an economic moat?
Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Northeast Pharmaceutical Group Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) is Hold, based on a StockRank of 64/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Northeast Pharmaceutical Group Co., Ltd. in?
Northeast Pharmaceutical Group Co., Ltd. (000597.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).